Space startup Cowboy Space Corporation ( previously Aetherflux) has filed with the FCC for a new 20,000-satellite NGSO ...
Rocket Pharmaceuticals has withdrawn its application seeking Food and Drug Administration approval of its RP-L102 proposed gene therapy for the treatment of the rare, inherited blood disorder Fanconi ...
The suit marks the latest escalation in a bitter personal and business feud between Rocket Companies chairman Dan Gilbert and ...
Shares of Rocket Pharmaceuticals surged after the Food and Drug Administration accepted its resubmitted application for its Kresladi drug to treat severe Leukocyte Adhesion Deficiency-I, a rare ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results